Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Successful use of dupilumab in a patient with atopic dermatitis and autosomal dominant polycystic kidney disease: a case report

    Arlind Kalaja, Barbara Cocuroccia, Donatella Sordi, Anna Dattolo, Sabatino Pallotta, Ignazio Stanganelli, Filomena Russo
    04-06-2026
    https://doi.org/10.4081/dr.2026.10522
    423
    PDF: 243
  • Urinary leukotriene e4 level profile in various degrees of severity in atopic dermatitis patients in dermatovenereology outpatient clinic Dr. Soetomo General Hospital, Surabaya: A descriptive study

    Meita Ardini Pratamasari, M. Marsoedi Hoetomo, Afif Nurul Hidayati
    29-03-2019
    https://doi.org/10.4081/dr.2019.8061
    1191
    PDF: 505
  • Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient Use of upadacitinib in pediatric comorbidities

    Edoardo Mortato, Ludovico Maria Rao, Marina Aloi, Arnaldo Cioni, Enrico Matteini, Angela Fico, Sara Lambiase, Ruslana Gaeta Shumak, Luca Bianchi, Elena Campione, Laura Diluvio
    09-01-2026
    https://doi.org/10.4081/dr.2026.10165
    879
    PDF: 578
  • Eczema Herpeticum in Pregnancy

    Grigoriy E. Gurvits, Jill A. Nord
    e32
    29-09-2011
    https://doi.org/10.4081/dr.2011.e32
    2484
    PDF: 945
    HTML: 145
  • Secondary prevention of hidradenitis suppurativa

    Hjalmar Kurzen, Marina Kurzen
    25-10-2019
    https://doi.org/10.4081/dr.2019.8243
    3149
    PDF: 1265
    HTML: 48
  • 11 | EFFICACY AND SAFETY OF LEBRIKIZUMAB IS MAINTAINED UP TO 4 YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: FIRST YEAR OF ADLONG LONG-TERM EXTENSION TRIAL L. Stingeni1, S. Weidinger2, A. Irvine3, D. Thaçi4, J. Szepietowski5, T. Biedermann6, H. Agell7, Y. Mihaylov7, B. Kostov7, R. Coll7, W. Romero8, K. Reich9 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 4Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 5Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland; 6Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany; 7Almirall S.A., Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11078
    141
    PDF: 85
  • 10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11077
    231
    PDF: 161
  • Addressing management gaps in atopic dermatitis: a behavioral analysis in Italian dermatology centers

    Marco Galluzzo, Ilaria Trave
    26-10-2026
    https://doi.org/10.4081/dr.2026.10948
    135
    PDF: 93
  • Acne exacerbation after tofacitinib treatment for alopecia areata

    Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser
    01-01-2022
    https://doi.org/10.4081/dr.2022.9396
    2695
    PDF: 900
    HTML: 45
  • Atopic dermatitis in adolescence

    Giampaolo Ricci, Federica Bellini, Arianna Dondi, Annalisa Patrizi, Andrea Pession
    e1
    19-12-2011
    https://doi.org/10.4081/dr.2012.e1
    6478
    PDF: 1542
    HTML: 143
  • Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement

    Edoardo Mortato, Claudia Paganini, Marina Talamonti, Virginia Maffei, Alfredo Belcastro, Cosimo Di Raimondo, Lorenzo Tofani, Luca Bianchi, Marco Galluzzo
    30-07-2026
    https://doi.org/10.4081/dr.2026.10460
    799
    PDF: 283
  • Hidradenitis suppurativa characterized by type 2-skewed inflammatory features when associated with atopic dermatitis: critical appraisal of a dupilumab-treated case report

    Niccolò Gori, Elena Ippoliti, Flaminia Antonelli, Ludovica Manieri, Ketty Peris
    15-07-2026
    https://doi.org/10.4081/dr.2026.10292
    388
    PDF: 218
  • Bacterial colonization of psoriasis plaques. Is it relevant?

    Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer
    e14
    05-08-2011
    https://doi.org/10.4081/dr.2011.e14
    1762
    PDF: 786
    HTML: 639
  • Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris

    Oki Suwarsa, Hartati Purbo Dharmadji, Endang Sutedja, Lengga Herlina, Putri Reno Sori, Reti Hindritiani, Reiva Farah Dwiyana, Hendra Gunawan
    20-06-2019
    https://doi.org/10.4081/dr.2019.8006
    1718
    PDF: 780
    HTML: 64
  • Eosinophilic annular erythema: four additional cases and a review of the literature on therapeutic options

    Andrea Corio, Simona Sola, Iris Zalaudek, Cesare Massone
    16-01-2026
    https://doi.org/10.4081/dr.2026.10168
    1052
    PDF: 457
    SUPPLEMENTARY MATERIAL: 14
    HTML: 0
  • 30 | ATOPIC DERMATITIS AND ULCERATIVE COLITIS: A CASE REPORT ON THE MANAGEMENT OF OVERLAPPING COMORBIDITIES S. Senatore1, C. Cardinali1, A. Pieraccini2, F. Taviti1 | 1SOC Dermatologia Pistoia-Prato, USL Toscana Centro, Italy; 2SOC Gastroenterologia ed Endoscopia, USL Toscana Centro, Italy

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11092
    229
    PDF: 96
  • Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literature

    Ora Bitterman-Deutsch, Leonid Kogan, Faris Nasser
    30-03-2015
    https://doi.org/10.4081/dr.2015.5851
    4520
    PDF: 1745
    HTML: 1985
  • Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

    Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani
    18-05-2023
    https://doi.org/10.4081/dr.2023.9700
    1243
    PDF: 406
    APPENDIX S1: 226
    HTML: 20
  • Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

    Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash
    29-01-2025
    https://doi.org/10.4081/dr.2025.10257
    924
    PDF: 428
    SUPPLEMENTARY MATERIAL: 98
    HTML: 14
  • 12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; 5Chang Gung University College of Medicine, Taoyuan, TW; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; 8Department of Dermatology and Population Health Sciences, King’s College London, London, UK; 9Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; 11Eli Lilly and Company, Indianapolis, Indiana,US; 12Almirall R&D, S.A., Barcelona, ES; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11079
    244
    PDF: 78
  • Soluble CD27 and MIF as possible serum biomarkers of vitiligo activity in Egyptian patients in Sharkia Governorate

    Mohamed Ibrahim El-Ghareeb, Sahar ElMokadem, Basma Elsayed, Naglaa Khalifa
    20-12-2019
    https://doi.org/10.4081/dr.2019.8265
    1142
    PDF: 735
    HTML: 42
  • The association between activity levels and skin moisturising function in adults

    Ryosuke Oizumi, Yoshie Sugimoto, Hiromi Aibara
    17-03-2021
    https://doi.org/10.4081/dr.2021.8811
    5129
    PDF: 1136
    HTML: 53
  • Erythrodermic psoriasis improved by tildrakizumab

    Giampaolo Trevisan, Lerica Germi, Luigi Naldi
    23-11-2022
    https://doi.org/10.4081/dr.2022.9448
    1382
    PDF: 647
    HTML: 29
  • Vitiligo: What’s old, what’s new

    Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli
    15-09-2021
    https://doi.org/10.4081/dr.2021.9142
    2969
    PDF: 1208
    HTML: 236
  • Sensitive scalp: an epidemiologic study in patients with hair loss

    Anna Graziella Burroni, Ilaria Trave, Astrid Herzum, Aurora Parodi
    26-01-2022
    https://doi.org/10.4081/dr.2022.9408
    1957
    PDF: 968
    HTML: 37
51 - 75 of 95 items << < 1 2 3 4 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.